Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Epidemiologic , Observational, Prospective Study to Assess the Prognostic Value of the Antithrombin III in the Development of Moderate or Severe Acute Pancreatitis (AT-PROPANC)

NCT02373293 is registered in ClinicalTrials.gov with Francisco Javier García Borobia as lead sponsor.

NCT NCT02373293
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02373293 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Epidemiologic , Observational, Prospective Study to Assess the Prognostic Value of the Antithrombin III in the Development of Moderate or Severe Acute Pancreatitis (AT-PROPANC)
Lead sponsor
Francisco Javier García Borobia
Phase
Observational
Overall status
Unknown status
Start date
January 18, 2015
Completion date
August 31, 2017
Enrollment
400 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute pancreatitis